Isofol Medical Abpublis A Biotechnology Company Based In Gothenburgswedenthe Company Is Dedicated To Improving Outcomes For Patients With Severe Forms Of Cancerfocusing Primarily On Innovative Oncology Drugsisofol Is Publicly Traded On Nasdaq Stockholmreflecting Its Commitment To Transparency And Accountability The Main Product Of Isofol Is Arfolitixorina Drug Candidate Aimed At Enhancing The Effectiveness Of Standard Treatments For Various Solid Tumorscurrentlyarfolitixorin Is Undergoing Clinical Trials For Colorectal Cancerwhich Is Among The Most Common Cancers Worldwideisofol Is Also Known For Its Previous Development Of Modufolina Designed To Improve Chemotherapy Results For Colorectal Cancer Patientsthe Company Seeks To Collaborate With Larger Pharmaceutical Firms To Expand The Reach Of Its Products And Enhance Treatment Options For Cancer Patients Globally
No conferences found for this company.
| Company Name | Isofol Medical Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
